首页|CREB1和CREB3在胃癌及癌前病变组织中的表达及其临床意义

CREB1和CREB3在胃癌及癌前病变组织中的表达及其临床意义

扫码查看
目的 探究环磷腺苷反应元件结合蛋白 1(CREB1)和环磷腺苷反应元件结合蛋白 3(CREB3)在胃癌及癌前病变组织中的表达及临床意义.方法 收集慢性浅表性胃炎40 例,慢性萎缩性胃炎伴肠化生40 例,异型增生40 例,胃癌50 例,采用免疫组化法检测CREB1 和CREB3 在四种组织中的表达,并分析其与临床病理参数的关系.另收集同期新鲜组织慢性浅表性胃炎、慢性萎缩性胃炎伴肠化生、胃癌共 30 例,应用蛋白印迹法(Western blot)检测CREB1 和CREB3 在不同胃组织中的表达.利用Kaplan-Meier plotter分析CREB1 和CREB3 的表达与胃癌患者总生存时间(OS)和无进展生存时间(FP)的相关性.利用STRING数据库分析CREB1 和CREB3 在信号通路中的位置以及与之相关的上下游基因.结果 免疫组化显示:胃癌组、异型增生组、萎缩性胃炎伴肠化生组CREB1、CREB3 阳性表达率明显高于慢性浅表性胃炎组(P<0.05);并且 CREB1、CREB3 在胃癌组的阳性表达率明显高于慢性萎缩性胃炎伴肠化生组(P<0.05),但与异型增生组无统计学差异(P>0.05).临床病理参数分析得出两者表达水平与浸润深度、TNM分期、脉管侵犯、淋巴结转移相关(P<0.05);与患者性别、年龄、肿瘤大小、分化程度无明显相关性(P>0.05).Western blot结果显示:CREB1、CREB3 蛋白表达在慢性浅表性胃炎、慢性萎缩性胃炎伴肠化生、胃癌中依次增高,差异有统计学意义(P<0.01).Kaplan-Meier plotter分析显示CREB1、CREB3 高表达的胃癌患者OS和FP均缩短.结论 CREB1、CREB3 可能与胃癌的发生、发展与转移相关,且蛋白高表达可能与胃癌患者预后不良有关.
Expression and Clinical Significance of CREB1 and CREB3 in Gastric Cancer and Pre-cancerous Lesions
Objective To investigate the expression and clinical significance of cAMP responsive element binding pro-tein 1(CREB1)and cAMP responsive element binding protein 3(CREB3)in gastric cancer and precancerous lesions.Methods 40 cases of chronic superficial gastritis,40 cases of chronic atrophic gastritis with intestinal metaplasia,40 cases of dysplasia,and 50 cases of gastric cancer were collected.The expressions of CREB1 and CREB3 in the 4 tissues were detected by immunohisto-chemical method,and the relationship between CREB3 and clinicopathological parameters was analyzed.A total of 30 cases of chronic superficial gastritis,chronic atrophic gastritis with intestinal metaplasia and gastric cancer were collected from fresh tissues during the same period.Western blot was used to detect the expression of CREB1 and CREB3 in different gastric tissues.Kaplan-Meier plotter was used to analyze the correlation between the expression of CREB1 and CREB3 and the overall survival time(OS)and progression-free survival time(FP)of gastric cancer patients.The position of CREB1 and CREB3 in signaling pathway and the upstream and downstream genes related to them were analyzed using STRING database.Results Immunohistochemistry showed that the positive expressions of CREB1 and CREB3 in gastric cancer group,dysplasia group,atrophic gastritis with intesti-nal metaplasia group were significantly higher than those in chronic superficial gastritis group(P<0.05).The positive expression rates of CREB1 and CREB3 in gastric cancer group were significantly higher than those in chronic atrophic gastritis with intestinal metaplasia(P<0.05),but there was no significant difference between them and dysplasia group(P>0.05).Analysis of clinico-pathological parameters showed that the expression levels of both were correlated with depth of invasion,TNM stage,vascular inva-sion and lymph node metastasis(P<0.05).There was no significant correlation with gender,age,tumor size and differentiation degree(P>0.05).Western blot results showed that the expression of CREB1 and CREB3 protein increased in chronic superficial gastritis,chronic atrophic gastritis with intestinal metaplasia and gastric cancer,with statistical significance(P<0.01).Kaplan-Meier plotter analysis showed that both OS and FP were shortened in gastric cancer patients with high CREB1 and CREB3 expres-sion.Conclusion CREB1 and CREB3 may be related to the occurrence,development and metastasis of gastric cancer,and the high expression of CREB1 and CREB3 may be related to the poor prognosis of gastric cancer patients.

Gastric cancerCREB1CREB3ImmunohistochemistryWestern blot

刘中华、任丽梅、孟宪梅、王驰、苏琪皓、田二青

展开 >

014000 包头医学院第二附属医院

胃癌 CREB1 CREB3 免疫组化 Western blot

内蒙古自治区科技计划

2021GG0232

2024

实用癌症杂志
江西省肿瘤医院 江西省肿瘤研究所

实用癌症杂志

影响因子:1.241
ISSN:1001-5930
年,卷(期):2024.39(4)
  • 20